High-Risk Labeling Error in ICU Medical Potassium Chloride Injection
Key Clinical Summary
- Product recall: ICU Medical’s potassium chloride Injection 10 mEq/100 mL (NDC 0990-7074-26), Lot 1030613 (exp. 09/30/2026), recalled under FDA Class I due to a critical labeling issue.
- Reason for recall: Overwrap label may incorrectly state 10 mEq instead of the intended 20 mEq strength, posing significant risk in dosing accuracy for this high-alert medication.
- Scope: US nationwide voluntary recall initiated 10/29/2025; notifications issued by letter; recall remains ongoing.
A nationwide Class I recall has been issued for potassium chloride injection, 10 mEq total in 100 mL (100 mEq/L) flexible containers, manufactured by ICU Medical, Inc and distributed by Otsuka ICU Medical LLC. The affected product carries NDC 0990-7074-26, Lot 1030613, with an expiration date of 09/30/2026. The recall was initiated on October 29, 2025, with US Food and Drug Administration (FDA) classification finalized on November 24, 2025, and notifications to customers issued by letter. Distribution was US nationwide, and the event remains ongoing.
The recall was prompted by a labeling defect: the overwrap label may incorrectly identify the product as potassium chloride injection 10 mEq instead of the intended 20 mEq concentration. This discrepancy introduces risk for potential underdosing or inappropriate dosing decisions, particularly in acute or critical care environments where potassium replacement therapy requires precision. Because potassium chloride is a high-alert medication, any strength mislabeling is taken seriously due to the potential for severe electrolyte imbalance, cardiac arrhythmia, or other life-threatening adverse events.
For clinical context, potassium chloride injection is used to treat or prevent hypokalemia in situations where oral supplementation is inadequate, impractical, or not tolerated—commonly in hospitalized or ICU patients requiring controlled IV replacement. Pharmacists should verify on-hand inventory, isolate affected lots, and ensure staff awareness to prevent administration errors related to this labeling issue.


